Related Experiment Video
Updated: Jul 17, 2026
04:55
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Simulating mild systematic and focal demyelinating neuropathies: membrane property abnormalities
D I Stephanova1, A S Alexandrov
1Institute of Biophysics, Bulgarian Academy of Sciences, Acad. G. Bontchev Str., Bl. 21, Sofia 1113, Bulgaria. dsteph@shiva.bio.bas.bg
Journal of Integrative Neuroscience
|January 25, 2007
Summary
Numerical simulations reveal that systematic demyelination significantly alters nerve fiber properties, unlike mild focal demyelination. Excitability tests effective for systematic conditions may fail to detect focal demyelinations.
Area of Science:
- Neuroscience
- Computational Biology
- Biophysics
Background:
- Demyelinating neuropathies involve damage to the myelin sheath surrounding nerve fibers.
- Understanding the distinct effects of different demyelination patterns (internodal, paranodal) is crucial for diagnosis and treatment.
- Current diagnostic tools may not adequately differentiate between various forms of demyelination.
Purpose of the Study:
- To numerically simulate and compare the effects of systematic and focal internodal, paranodal, and combined demyelination on human motor nerve fibers.
- To assess the utility of axonal excitability indices in detecting different demyelination patterns.
- To validate the simulation model against clinical data from demyelinating diseases.
Main Methods:
- Utilized a double cable model of human motor nerve fibers.
- Simulated a 70% reduction in myelin lamellae (internodal) or paranodal seal resistance (paranodal), or both.
- Investigated both uniform (systematic) and localized (focal) demyelination across 30 nodes and 29 internodes.
- Analyzed changes in membrane properties and axonal excitability indices.
Main Results:
- Systematic demyelination (internodal, paranodal, or both) caused significant membrane property abnormalities.
- Focal demyelination resulted in minimal changes to excitability indices, often indistinguishable from normal.
- Simulated systematic demyelination aligned with patient data from Charcot-Marie-Tooth disease type 1A (CMT1A) and chronic inflammatory demyelinating polyneuropathy (CIDP).
- Simulated focal demyelination matched observations in Guillain-Barré syndrome (GBS).
Conclusions:
- Axonal excitability testing may be ineffective for detecting mild focal demyelinations.
- The computational model is a promising tool for understanding demyelinating neuropathies.
- Distinguishing between systematic and focal demyelination is critical for accurate diagnosis and understanding disease mechanisms.
